Avidity Partners Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.4M Buy
155,600
+105,300
+209% +$14.7M 1.96% 9
2025
Q4
$8.24M Buy
50,300
+27,000
+116% +$4.23M 2.38% 10
2025
Q3
$3.11M Sell
23,300
-83,200
-78% -$10.1M 0.71% 31
2025
Q2
$13.2M Buy
+106,500
New +$13.6M 2.64% 12

Other funds holding RGEN

Avidity Partners Management's RGEN Position: Q1 2026 in Review

Avidity Partners Management increased its Repligen (RGEN) stake by 209% in Q1 2026, buying an estimated $14.7M and bringing the position to 155,600 shares worth $18.4M. The position accounts for 1.96% of the portfolio, ranked #9.

Avidity Partners Management first reported a position in RGEN in Q2 2025 and has held it in 4 quarters since. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Avidity Partners Management held 155,600 shares of Repligen worth $18.4M as of Q1 2026.
  • Avidity Partners Management bought 105,300 Repligen shares in Q1 2026, an estimated $14.7M.
  • Repligen made up 1.96% of Avidity Partners Management's portfolio in Q1 2026, its #9 holding.
  • Avidity Partners Management first reported a position in Repligen in Q2 2025 and has held it in 4 quarters since.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Avidity Partners Management's 13F filing for Q1 2026, filed 13 May 2026.